Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

PDRN viscosity determination is a critical quality control test for polydeoxyribonucleotide-based injectables, cosmetics, and pharmaceutical raw materials, ensuring consistent injectability, flow behavior, and product performance. This technical article outlines the testing samples, measurable parameters, standard methods, and practical applications of PDRN viscosity analysis in accordance with international pharmacopoeial standards.

PDRN

Technical Overview

Polydeoxyribonucleotide (PDRN) is a linear DNA-derived polymer, most commonly extracted and purified from salmon sperm or salmon testes, with a typical molecular weight range of 80 to 2,000 kDa depending on the production process. PDRN is widely used in aesthetic medicine as a skin booster and regenerative injectable, in wound healing products, and as a functional ingredient in high-end cosmetics. Because PDRN is a high-molecular-weight polynucleotide, its dilute and concentrated solutions exhibit measurable flow resistance that directly reflects the polymer's chain length, concentration, purity, and hydration state.

Viscosity is recognized as a critical quality attribute (CQA) for PDRN products. It governs syringeability and injectability through fine-gauge needles, influences the in-vivo residence time and diffusion profile of injected formulations, affects the sensory texture of topical cosmetics, and serves as an indirect indicator of molecular weight and degradation status. A significant drop in viscosity may signal depolymerization caused by heat, shear, enzymatic contamination, or hydrolysis, while abnormally high viscosity may indicate aggregation, excessive concentration, or process deviation. Systematic PDRN viscosity determination therefore supports batch release, formulation optimization, stability evaluation, and regulatory compliance under frameworks such as NMPA drug registration, CE marking for medical devices, and cosmetic product safety assessment.

Testing Samples

PDRN Injectable Solutions

Ready-to-use PDRN sodium salt solutions, typically supplied in ampoules, vials, or pre-filled syringes at concentrations of 1.0 to 3.0 percent, represent the most common sample type. These samples are tested as received after equilibration to the specified measurement temperature, with minimal pre-treatment to avoid shear-induced molecular degradation.

Reconstituted PDRN Lyophilized Powder

PDRN freeze-dried powders are reconstituted with sterile water for injection or the designated diluent to the labeled concentration before testing. The dissolution procedure must be standardized, including resting time for complete hydration, because incomplete swelling leads to underestimation of viscosity.

PDRN Bulk Substance and Cosmetic Raw Materials

Manufacturers of finished products often test incoming PDRN raw material by preparing reference solutions at a defined concentration in a specified buffer. This verifies both the intrinsic viscosity of the polymer and lot-to-lot consistency of the supply chain.

PDRN Combination Formulations

Hybrid products containing PDRN blended with hyaluronic acid, amino acids, peptides, or vitamins are tested to characterize the combined rheological profile. For these samples, viscosity data help confirm blend uniformity and detect interactions between PDRN and the co-formulated polymers.

Stability Study Samples

Retained samples from accelerated and long-term storage conditions, including refrigerated, room temperature, and temperature-cycled storage, are tested periodically to monitor viscosity drift over the claimed shelf life.

Testing Items

Depending on the product type and regulatory purpose, the following viscosity-related parameters can be determined:

  • Dynamic (absolute) viscosity: expressed in millipascal-seconds, measured primarily by rotational viscometry for finished PDRN solutions.
  • Kinematic viscosity: expressed in square millimeters per second, obtained with capillary viscometers and convertible to dynamic viscosity via density.
  • Relative viscosity and specific viscosity: ratios of solution viscosity to solvent viscosity, used for dilute PDRN solutions.
  • Intrinsic viscosity (limiting viscosity number): extrapolated to zero concentration, applied for molecular weight estimation of PDRN using the Mark-Houwink relationship.
  • Shear rate dependence: characterization of Newtonian or non-Newtonian flow behavior across multiple rotational speeds or shear rates.
  • Temperature dependence: viscosity profiles at 20, 25, and 37 degrees Celsius to predict room-temperature handling and in-vivo injection performance.
  • Flow-through and consistency parameters: torque readings, spindle factors, and percent-scale values documented for batch-to-batch comparability.

Testing Methods

Rotational Viscometry

Rotational viscometry, typically performed with a Brookfield-type instrument, is the primary method for PDRN injectable solutions. A suitable spindle, such as an LV-1 or UL adapter for low-viscosity aqueous solutions, is immersed in the sample contained in a controlled-temperature vessel at 25 plus or minus 0.2 degrees Celsius. The measurement is performed at a defined rotational speed, and readings are taken once the torque value stabilizes. The procedure follows the general requirements of Chinese Pharmacopoeia General Chapter 0633, USP General Chapter 911, and European Pharmacopoeia Method 2.2.10. Key controls include eliminating air bubbles, avoiding evaporation, using an adequate sample volume, and recording spindle number and speed alongside the result.

Capillary Viscometry

For dilute PDRN solutions and intrinsic viscosity determination, Ubbelohde or Ostwald-Fenske capillary viscometers are used. The flow time of the solution and of the pure solvent is measured in a constant-temperature bath, and the kinematic viscosity is calculated by multiplying the flow time by the viscometer constant. A series of diluted concentrations allows extrapolation of reduced and inherent viscosity to zero concentration, yielding the intrinsic viscosity, which correlates with PDRN molecular weight.

Cone-and-Plate and Parallel-Plate Rheometry

When complete rheological characterization is required, for example during formulation development of PDRN-hyaluronic acid hybrids, a controlled-stress rheometer with a cone-and-plate geometry provides continuous shear sweep data, yield behavior, and oscillatory parameters such as storage and loss modulus. This method reveals shear-thinning behavior that a single-point Brookfield reading cannot capture.

Rolling Ball Viscometry

For transparent, low-viscosity PDRN solutions with limited sample volume, a rolling ball (Hoeppler) viscometer offers a reproducible alternative, measuring the time for a calibrated ball to roll through an inclined capillary filled with the sample.

Method Selection and Validation Considerations

The chosen method must be justified by the expected viscosity range, sample availability, and regulatory expectations. Method validation or verification typically covers suitability of the spindle or capillary size, precision (repeatability and intermediate precision), robustness to temperature fluctuation, and, where applicable, comparison against a certified viscosity reference standard. Calibration of instruments with certified traceable oils at regular intervals is mandatory for data integrity.

Applications

  • Quality control and batch release of PDRN injections, ensuring each lot meets the viscosity specification stated in the regulatory dossier.
  • Molecular weight and degradation monitoring, where viscosity decline indicates depolymerization of the PDRN chain during processing or storage.
  • Formulation development, guiding the selection of PDRN concentration, buffer composition, and co-polymers to achieve target injectability through 27G to 32G needles.
  • Stability studies supporting shelf-life claims, including accelerated aging at elevated temperature and real-time storage condition monitoring.
  • Comparative studies between PDRN products and combination skin booster formulations for research and marketing support documentation.
  • Supplier qualification and incoming material control for cosmetic and pharmaceutical manufacturers sourcing PDRN sodium salt.
  • Regulatory submission support, providing viscosity data packages for NMPA drug applications, FDA submissions, CE technical files, and cosmetic product safety reports.

FAQ

What is the typical viscosity of a PDRN injectable solution?

A 1 to 2 percent aqueous PDRN sodium salt solution generally exhibits low viscosity, often in the range of approximately 1 to 10 mPa·s at 25 degrees Celsius, depending on molecular weight and salt concentration. The exact acceptance limits are product-specific and defined by the manufacturer's specification.

Which viscosity method is most appropriate for PDRN products?

Rotational viscometry with a low-viscosity adapter is preferred for finished injectable solutions because of its simplicity and pharmacopoeial recognition. Capillary viscometry is preferred when intrinsic viscosity and molecular weight estimation are required.

At what temperature should PDRN viscosity be measured?

Common specification temperatures are 20 or 25 degrees Celsius for release testing, with 37 degrees Celsius sometimes added to simulate physiological injection conditions. Temperature must be controlled within plus or minus 0.2 degrees Celsius because viscosity decreases significantly with rising temperature.

How is PDRN molecular weight related to viscosity?

For linear polynucleotides such as PDRN, viscosity increases with molecular weight and concentration. Intrinsic viscosity measurements, combined with an appropriate Mark-Houwink relationship, provide an estimate of the weight-average molecular weight, which is useful when direct size-exclusion chromatography data are unavailable.

Why did my PDRN sample show lower viscosity than the specification?

Frequent causes include thermal or enzymatic degradation of the polymer chain, dilution error, incomplete dissolution of lyophilized powder, measurement at an incorrect temperature, or shear history during sample handling. Investigating storage conditions and repeating the test with fresh equilibrated sample is recommended before concluding a quality defect.

How much sample is required for a viscosity test?

Rotational viscometry with a standard small-sample adapter typically requires 5 to 20 mL, while UL adapters and capillary viscometers can work with 1 to 5 mL, making them suitable for limited-volume retained samples.